This gene facilitates the activation of the FAK pathway through RTK signaling, triggering the ERK/MAPK signaling pathways and conferring resistance to MEK inhibition in tumor cells (Yu et al., 2022). The gene discussed is MAP2K7; the disease is neoplasm.